Skip to main content
. 2021 Jul 9;8(5):3769–3782. doi: 10.1002/ehf2.13445

Figure 2.

Figure 2

Survival curves for time‐to‐event study. (A) The survival probability in different groups of change in CRP in women and risk of HF. (B) The survival probability of different groups of change in CRP in women (left) and men (right) and risk of other CVD. (C) The survival probability in different groups of change in IL‐6 and risk of all‐cause mortality in men. CRP, C‐reactive protein; HF, heart failure; CVD, cardiovascular disease.